The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions
Neurochemical Research · 2024-02 · 49 (2) · 453-465
DOI: 10.1007/s11064-023-04052-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 28.10.2023. Verfasst von Andrei N Tsentsevitsky und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31 Lobachevsky …. Hauptthemen laut MEDLINE: Synaptic Transmission, Neuromuscular Junction. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
α2-Adrenoreceptors (ARs) are main Gi-protein coupled autoreceptors in sympathetic nerve terminals and targets for dexmedetomidine (DEX), a widely used sedative. We hypothesize that α2-ARs are also potent regulators of neuromuscular transmission via G protein-gated inwardly rectifying potassium (GIRK) channels. Using extracellular microelectrode recording of postsynaptic potentials, we found DEX-induced inhibition of spontaneous and evoked neurotransmitter release as well as desynchronization of evoked exocytotic events in the mouse diaphragm neuromuscular junction. These effects were suppressed by SKF-86,466, a selective α2-AR antagonist. An activator of GIRK channels ML297 had the same effects on neurotransmitter release as DEX. By contrast, inhibition of GIRK channels with tertiapin-Q prevented the action of DEX on evoked neurotransmitter release, but not on spontaneous exocytosis. The synaptic vesicle exocytosis is strongly dependent on Ca2+ influx through voltage-gated Ca2+ channels (VGCCs), which can be negatively regulated via α2-AR - GIRK channel axis. Indeed, inhibition of P/Q-, L-, N- or R-type VGCCs prevented the inhibitory action of DEX on evoked neurotransmitter release; antagonists of P/Q- and N-type channels also suppressed the DEX-mediated desynchronization of evoked exocytotic events. Furthermore, inhibition of P/Q-, L- or N-type VGCCs precluded the frequency decrease of spontaneous exocytosis upon DEX application. Thus, α2-ARs acting via GIRK channels and VGCCs (mainly, P/Q- and N-types) exert inhibitory effect on the neuromuscular communication by attenuating and desynchronizing evoked exocytosis. In addition, α2-ARs can suppress spontaneous exocytosis through GIRK channel-independent, but VGCC-dependent pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31 Lobachevsky St, Kazan, 420111, RT, Russia.
- Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31 Lobachevsky St, Kazan, 420111, RT, Russia. alexey.petrov@kazangmu.ru.
- Kazan State Medical University, 49 Butlerova St, Kazan, 420012, RT, Russia. alexey.petrov@kazangmu.ru.
- Kazan Federal University, 18 Kremlyovskaya Street, Kazan, 420008, Russia. alexey.petrov@kazangmu.ru.
Förderung
- Russian Science Foundation
Zitieren
APA
Tsentsevitsky, A. N., Khuzakhmetova, V. F., Bukharaeva, E. A., & Petrov, A. M. (2024). The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions. Neurochemical Research, 49(2), 453-465. https://doi.org/10.1007/s11064-023-04052-1
Vancouver
Tsentsevitsky AN, Khuzakhmetova VF, Bukharaeva EA, Petrov AM. The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions. Neurochemical Research. 2024;49(2):453-465. doi:10.1007/s11064-023-04052-1
BibTeX
@article{Tsentsevitsky2024,
author = {Tsentsevitsky, Andrei N and Khuzakhmetova, Venera F and Bukharaeva, Ellya A and Petrov, Alexey M},
title = {The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions},
journal = {Neurochemical Research},
year = {2024},
volume = {49},
number = {2},
pages = {453--465},
doi = {10.1007/s11064-023-04052-1}
}
EUVIMED